Justin Oldham, M.D., M.S.

Justin Michael Oldham, M.D., M.S.


Pulmonary Medicine

Critical Care Medicine


  • Assistant Professor of Medicine
  • Director, Interstitial Lung Disease Program


To see if Justin Michael Oldham is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Medical Group - Sacramento (J Street)

2825 J St., Suite 400
Sacramento, CA 95816
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Fax: 916-734-0804
Clinic Referral Phone: 916-734-8230
Physician Referrals: 800-4-UCDAVIS (800-482-3284)



Clinical Interests

Dr. Oldham is a pulmonologist with expertise in Interstitial Lung Disease (ILD), including idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, and connective tissue disease-related interstitial lung disease. He serves as director of the ILD clinical and research program at UC-Davis and oversees the ILD patient registry and biorepository. 

Research/Academic Interests

Dr. Oldham's research interests lie in early ILD detection and translating biomarker research into clinical application.


Pulmonary, Critical Care, and Sleep Medicine
UC Davis Medical Group, Sacramento - J Street

Center/Program Affiliation

UC Davis Medical Group


M.D., University of Colorado School of Medicine, Denver CO 2006

M.S., Biostatistics and Epidemiology, University of Chicago, Chicago IL 2015

B.A., University of Colorado, Boulder CO 2002

Internship: Internal Medicine, UC Davis Medical Center, Sacramento CA 2006-2007


Internal Medicine, UC Davis Medical Center, Sacramento CA 2007-2009


Pulmonary and Critical Care, University of Chicago, Chicago IL 2011-2016

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Critical Care Medicine, 2014

American Board of Internal Medicine, Pulmonary and Critical Care Medicine,

American Board of Internal Medicine, Pulmonary Medicine, 2013

Professional Memberships

American College of Chest Physicians

American Thoracic Society

European Respiratory Society

Honors and Awards

Intl Colloquium on Lung and Airway Fibrosis Scientific Merit Award, 2018

American College of Chest Physicians Pulmonary Fibrosis Award, 2018

Philip Thai Memorial Lung Research Award, 2016

Pulmonary Fibrosis Foundation Summit Poster Award, 2015

American Thoracic Society Clinical Problems Abstract Award, 2015

Janet Rowley Research Day Clinical Abstract Award, 2014

Medical Student Teaching Award, 2010

Select Recent Publications

Adegunsoye A, Oldham JM, Bellam SK, Chung JH, Chung PA, Biblowitz KM, Montner S, Lee C, Hsu S, Husain AN, Vij R, Mutlu G, Noth I, Churpek MM, Strek ME. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. The European respiratory journal. 2018;(51).

Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, Bellam S, Mehta U, Thakrar K, Pugashetti JV, Husain AN, Montner SM, Straus CM, Vij R, Sperling AI, Noth I, Strek ME, Chung JH. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment: An Observational Cohort Study with Independent Validation. American journal of respiratory and critical care medicine 2018.

Pugashetti J, Graham J, Boctor N, Mendez C, Foster E, Juarez M, Harper R, Morrissey B, Kadoch M, Oldham JM. Weight loss as a predictor of mortality in patients with interstitial lung disease. The European respiratory journal. 2018;(52).

Oldham JM, Adegunsoye A, Khera S, Lafond E, Noth I, Strek ME, Kadoch M, Chung JH. Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018;(15): 764-766.

Adegunsoye A, Oldham JM, Chung JH, Montner SM, Lee C, Witt LJ, Stahlbaum D, Bermea RS, Chen LW, Hsu S, Husain AN, Noth I, Vij R, Strek ME, Churpek M. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2017.

Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek ME. Characterization of patients with interstitial pneumonia with autoimmune features. European Respiratory Journal. 2016. 

Adegunsoye A, Oldham JM, Demchuk C, Montner S, Chung JH, Vij R, Strek ME. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respiratory Medicine. 2016. 

Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I; IPFnet Investigators. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015 Dec 15;192(12):1475-82.

Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth I. Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2015 Sep;148(3):692-700.

Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth I. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Nov 21;15:147.